We Work for Health of Massachusetts seeks to educate our elected leaders, the news media and the communities they serve about the important contributions these companies and their employees make to the health and economic security of individuals, local communities, and to the Commonwealth of Massachusetts.
The industry not only helps drive the Massachusetts economy, but also leads the world in life-saving research and supports a vibrant patient advocacy community. Biopharmaceutical research companies and their employees play a critical role in improving the health and well-being of Massachusetts’ patients by delivering life-saving, life-enhancing advancements in medicine. In addition to working to improve health and economic viability, many biopharmaceutical companies provide philanthropic outreach in local communities across Massachusetts through grants and programs supporting access to affordable health coverage and medicine, primary and secondary education, social services, arts, and other community needs.
The biopharmaceutical sector is the foundation of one of Massachusetts’ most dynamic innovation and business ecosystems. Not only does the industry invest heavily in the research and development of new treatments and cures, it also generates high quality jobs, powers economic output and exports for the U.S. economy and sustains a very large-scale supply chain.
Update
Learn more about We Work For Health in Massachusetts and how to get involved.
Supporting High Quality Jobs in Massachusetts
The innovative biopharmaceutical sector directly supported 72,147 jobs in Massachusetts in 2020. These jobs are often high-skill, high-wage professions.
The industry also supported another 216,443 jobs indirectly, for a total of about 288,590 jobs across the Massachusetts economy. These additional jobs are with vendors and suppliers such as construction companies and I.T. companies, and jobs generated by the sector’s employees such as day care centers and restaurants.
Massachusetts workers whose jobs were supported by the biopharmaceutical sector paid a total of $5.1 billion in personal taxes in 2020—$5.2 billion in federal taxes and $852 million in state taxes.
Massachusetts' Economic Impact
In 2020, the biopharmaceutical sector supported $81.1 billion in economic output for the state of Massachusetts—including $35.6 billion generated directly by the sector, and another $45.5 billion through its vendors and suppliers and through the economic activity of its workforce.
vendor relationships
vendor spending
$3,988,094,262
Partners
For more information on WWFH-MA, please contact us at info@weworkforhealth.org.
Join
Media
Travis Gregory was instrumental in creating Biogen’s new employee engagement platform, Biogen Political. It was no small task – it required modifying multiple IT, HR, compliance, legal and other processes to build a website accessible to employees. Thanks to the site and...
Travis Gregory was instrumental in creating Biogen’s new employee engagement platform, Biogen Political. It was no small task – it required modifying multiple IT, HR, compliance, legal and other processes to build a website accessible to employees. Thanks to the site and Travis’ hard work, Biogen’s voice to members of Congress and state and local officials can be heard. In addition to Travis’ support of Biogen’s public policy and government affairs team, he was nominated to serve on the Biogen PAC Board to help advise and grow the Biogen PAC.
